How Genomic Testing Helps Identify Patients At-risk for Diabetes

Today, World Diabetes Day, we celebrate the new discoveries and hope given to patients living with diabetes.

In recognition of the determination of countless researchers, providers, patients, and advocates involved in the fight against diabetes, our genomic and central laboratory experts have shared insights into the constant effort to better identify, treat, and care for those who are at-risk and living with diabetes.

In this World Diabetes Day blog, you will learn about:
  1. New genomic testing efforts underway to more precisely identify diabetes subgroups 
  2. Current challenges with genomic testing for diabetes such as identifying patient response to therapy
  3. Central laboratory testing methods for estimating insulin resistance
Diabetes Solutions

Genomic Assays for Clinical Development

Identifying the right approach from a wealth of potential options

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Read More